978 related articles for article (PubMed ID: 28625240)
1. [Dynamic changes of complement level in patients with acute coronary syndrome and its relationships with myocardial injury].
Shao A; Qi X; Li Q; Jia W; Wei L; Hou W; Qi Y; Liu Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jun; 29(6):515-519. PubMed ID: 28625240
[TBL] [Abstract][Full Text] [Related]
2. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome.
Ogawa A; Seino Y; Yamashita T; Ogata K; Takano T
Circ J; 2006 Nov; 70(11):1372-8. PubMed ID: 17062956
[TBL] [Abstract][Full Text] [Related]
3. Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial.
Batra G; Renlund H; Kunadian V; James SK; Storey RF; Steg PG; Katus HA; Harrington RA; Gibson CM; Budaj A; Siegbahn A; Wallentin L
Eur Heart J Acute Cardiovasc Care; 2022 Jun; 11(4):336-349. PubMed ID: 35213721
[TBL] [Abstract][Full Text] [Related]
4. Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF.
Liu H; Su Y; Shen J; Jiao Y; Li Y; Liu B; Hou X; Jin Q; Chen Y; Sun Z; Xi Q; Feng B; Fu Z
ESC Heart Fail; 2024 Apr; 11(2):937-949. PubMed ID: 38224955
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].
Liu WX; Zhao H
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085
[TBL] [Abstract][Full Text] [Related]
6. Complement activation in acute coronary syndromes.
Iltumur K; Karabulut A; Toprak G; Toprak N
APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
[TBL] [Abstract][Full Text] [Related]
7. Apelin in ST segment elevation and non-ST segment elevation acute coronary syndromes: a novel finding.
Cosansu K; Cakmak HA; Ikitimur B; Yildirim E; Can G; Karadag B; Koldas L
Kardiol Pol; 2014; 72(3):239-45. PubMed ID: 24142748
[TBL] [Abstract][Full Text] [Related]
8. [Trend of clinical features in patients with acute coronary syndrome undergoing emergent percutaneous coronary intervention].
Zhou JY; Liu C; Zhou P; Tan Y; Li JN; Sheng ZX; Zhao HJ; Song L; Yang YM; Wu Y; Yan HB
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Oct; 46(10):790-794. PubMed ID: 30369169
[No Abstract] [Full Text] [Related]
9. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
[TBL] [Abstract][Full Text] [Related]
10. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band.
Ruzgar O; Bilge AK; Bugra Z; Umman S; Yilmaz E; Ozben B; Umman B; Meric M
Heart Vessels; 2006 Sep; 21(5):309-14. PubMed ID: 17151819
[TBL] [Abstract][Full Text] [Related]
11. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.
Pilgrim T; Vranckx P; Valgimigli M; Stefanini GG; Piccolo R; Rat J; Rothenbühler M; Stortecky S; Räber L; Blöchlinger S; Hunziker L; Silber S; Jüni P; Serruys PW; Windecker S
Am Heart J; 2016 May; 175():56-65. PubMed ID: 27179724
[TBL] [Abstract][Full Text] [Related]
12. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
[TBL] [Abstract][Full Text] [Related]
13. [Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Li S; Fu X; Dai Y; Liu C; Wang Y; Li W; Wu W; Gu X; Hao G; Fan W; Miao Q; Jiang Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Nov; 43(11):954-9. PubMed ID: 26888806
[TBL] [Abstract][Full Text] [Related]
14. miR-941 as a promising biomarker for acute coronary syndrome.
Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
[TBL] [Abstract][Full Text] [Related]
15. Gamma-glutamyltransferase in acute coronary syndrome patients without ST elevation and its association with stenotic lesion and cardiac events.
Dogan A; Icli A; Aksoy F; Varol E; Erdogan D; Ozaydin M; Kocyigit S
Coron Artery Dis; 2012 Jan; 23(1):39-44. PubMed ID: 22107801
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the ischemic post-conditioning on the prevention of the cardio-renal damage in patients with acute ST-segment elevation myocardial infarction after primary percutaneous coronary intervention].
Wang YY; Li T; Liu YW; Liu BJ; Hu XM; Wang Y; Gao WQ; Wu P; Huang L; Li X; Peng WJ; Ning M
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Apr; 45(4):277-282. PubMed ID: 28545277
[No Abstract] [Full Text] [Related]
17. The diagnostic role of signal peptide-C1r/C1s, Uegf, and Bmp1-epidermal growth factor domain-containing protein 1 in non-ST-elevation acute coronary syndrome.
Sonmez E; Turkdogan KA; Karabacak M; Civelek C; Yilmaz C; Ozer OF; Çavuş UY
Am J Emerg Med; 2015 Jan; 33(1):21-4. PubMed ID: 25445868
[TBL] [Abstract][Full Text] [Related]
18. A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.
Dong M; Liao JK; Yan B; Li R; Zhang M; Yu CM
Int J Cardiol; 2013 Sep; 167(6):2813-9. PubMed ID: 22921817
[TBL] [Abstract][Full Text] [Related]
19. High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
Du Y; Zhao Y; Zhu Y; Hu C; Zhang J; Ji Q; Liu W; Han H; Yang L; Zhang D; Tong S; Wang Z; Guo Y; Liu X; Zhou Y
J Atheroscler Thromb; 2019 Oct; 26(10):868-878. PubMed ID: 30773518
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
